[go: up one dir, main page]

NO20002798D0 - Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker - Google Patents

Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker

Info

Publication number
NO20002798D0
NO20002798D0 NO20002798A NO20002798A NO20002798D0 NO 20002798 D0 NO20002798 D0 NO 20002798D0 NO 20002798 A NO20002798 A NO 20002798A NO 20002798 A NO20002798 A NO 20002798A NO 20002798 D0 NO20002798 D0 NO 20002798D0
Authority
NO
Norway
Prior art keywords
spermatozoa
motility
humans
compositions
concentration
Prior art date
Application number
NO20002798A
Other languages
English (en)
Other versions
NO20002798L (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26820998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002798(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/980,821 external-priority patent/US5863940A/en
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20002798D0 publication Critical patent/NO20002798D0/no
Publication of NO20002798L publication Critical patent/NO20002798L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002798A 1997-12-01 2000-05-31 Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker NO20002798L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/980,821 US5863940A (en) 1997-12-01 1997-12-01 Medicament and therapeutical method for treating idiopathic asthenozoospermia
US09/122,897 US6090848A (en) 1997-12-01 1998-07-28 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
PCT/IT1998/000324 WO1999027925A1 (en) 1997-12-01 1998-11-18 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans

Publications (2)

Publication Number Publication Date
NO20002798D0 true NO20002798D0 (no) 2000-05-31
NO20002798L NO20002798L (no) 2000-06-27

Family

ID=26820998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002798A NO20002798L (no) 1997-12-01 2000-05-31 Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker

Country Status (22)

Country Link
US (1) US6090848A (no)
EP (1) EP1039894B1 (no)
JP (1) JP2001524520A (no)
KR (1) KR20010032702A (no)
CN (1) CN1184966C (no)
AT (1) ATE206916T1 (no)
AU (1) AU749754B2 (no)
BR (1) BR9814711A (no)
CA (1) CA2314942C (no)
DE (1) DE69802113T2 (no)
DK (1) DK1039894T3 (no)
EE (1) EE200000309A (no)
ES (1) ES2163896T3 (no)
HU (1) HU228989B1 (no)
IL (1) IL136299A0 (no)
IS (1) IS5501A (no)
NO (1) NO20002798L (no)
PL (1) PL192438B1 (no)
PT (1) PT1039894E (no)
SK (1) SK7572000A3 (no)
TR (1) TR200001519T2 (no)
WO (1) WO1999027925A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383814C (en) * 1999-09-03 2010-08-17 Sigma-Tau Healthscience S.P.A. Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
ITRM20010029A1 (it) * 2001-01-23 2002-07-23 Aldo Fassi Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
HRP20040087A2 (en) * 2001-09-12 2004-12-31 Applied Research Systems USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
CA2457851A1 (en) * 2001-09-12 2003-03-20 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
ITRM20010621A1 (it) * 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
RU2215532C2 (ru) * 2001-12-10 2003-11-10 Тихоокеанский научно-исследовательский рыбохозяйственный центр Способ комплексной переработки внутренностей голотурий с получением биологически активных добавок к пище и биологически активные пищевые добавки "тингол-2" и "эрогол"
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
AT503219B1 (de) 2006-02-03 2008-07-15 Annerl Brigitte Kombinationspräparat auf basis von antioxidanzien zur verbesserung der samenqualität
DK2086642T3 (da) * 2006-10-18 2014-09-29 Periness Ltd Dnase til behandling af subfertilitet hos mænd
DE102007053369A1 (de) 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
WO2009068278A2 (en) * 2007-11-30 2009-06-04 Bayer Consumer Care Ag A pharmaceutical composition
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
JP6441345B2 (ja) * 2013-12-05 2018-12-19 アルファシグマ ソシエタ ペル アチオニ 雌の受胎能を促進するために有用な組成物
CN105695398A (zh) * 2016-04-25 2016-06-22 广西大学 含o-乙酰基-l-肉碱盐酸盐的水牛卵母细胞体外成熟液及培养方法
ES2813573T3 (es) * 2016-07-11 2021-03-24 Laboratoire Des Granions Composición que comprende L-carnitina para el tratamiento de la infertilidad masculina
CN107375346A (zh) * 2017-07-25 2017-11-24 昭远制药(上海)有限公司 提高人类精子浓度和运动性的组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235153B (it) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
IT1224795B (it) * 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240799B (it) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT1248323B (it) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1249462B (it) * 1991-10-21 1995-02-23 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento delle oligoastenospermie idiopatiche.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1261688B (it) * 1993-05-28 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1261696B (it) * 1993-06-02 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
IT1274156B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT1274157B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
US5889055A (en) * 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo

Also Published As

Publication number Publication date
CA2314942A1 (en) 1999-06-10
CN1184966C (zh) 2005-01-19
EP1039894A1 (en) 2000-10-04
HU228989B1 (en) 2013-07-29
TR200001519T2 (tr) 2000-11-21
IL136299A0 (en) 2001-05-20
PL342115A1 (en) 2001-05-21
HUP0004562A3 (en) 2003-05-28
CA2314942C (en) 2009-05-05
DE69802113T2 (de) 2002-06-06
HUP0004562A2 (hu) 2001-05-28
NO20002798L (no) 2000-06-27
IS5501A (is) 2000-05-19
SK7572000A3 (en) 2000-11-07
AU749754B2 (en) 2002-07-04
DE69802113D1 (de) 2001-11-22
US6090848A (en) 2000-07-18
JP2001524520A (ja) 2001-12-04
AU1259199A (en) 1999-06-16
HK1033280A1 (en) 2001-08-24
BR9814711A (pt) 2000-10-03
WO1999027925A1 (en) 1999-06-10
PL192438B1 (pl) 2006-10-31
EP1039894B1 (en) 2001-10-17
ATE206916T1 (de) 2001-11-15
KR20010032702A (ko) 2001-04-25
EE200000309A (et) 2001-08-15
PT1039894E (pt) 2002-04-29
DK1039894T3 (da) 2002-02-11
CN1284871A (zh) 2001-02-21
ES2163896T3 (es) 2002-02-01

Similar Documents

Publication Publication Date Title
NO20002798L (no) Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker
BR0107749A (pt) Métodos de uso de uma composição de bebida
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
MXPA05006194A (es) Metodo para utilizar una composicion de bebida.
PT951474E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
DK0693281T3 (da) Farmaceutiske fluoxetinformuleringer
BR9811099A (pt) Inibidores de urocinase
TR200101335T2 (tr) İktidarsızlık tedavisi için pirazolopirimidinon türevleri
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
KR950031059A (ko) 골다공증 치료용 약제학적 조성물
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
PT814789E (pt) Composicoes farmaceuticas compreendendo inibidores de monoamina-oxidase b
DK1056475T3 (da) Dendrimere fullerenderivater, fremgangsmåde til fremstilling heraf samt deres anvendelse som neuroprotektiva
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
FI973691A0 (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
IE840977L (en) Pharmaceutical preparations
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
DE69637209D1 (de) Aminoguanidine zur behandlung von diabetes typ ii
DE69626307D1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
FR2718965B1 (fr) Nouvelle application thérapeutique de la spiramycine.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application